Widespread, exceptionally high levels of histone H3 lysine 4 trimethylation largely mediate "privileged" gene expression

被引:0
作者
Chen, Li
Firozi, Pervez
Barton, Michelle
Templeton, Nancy Smyth
机构
[1] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA
来源
GENE EXPRESSION | 2007年 / 13卷 / 4-5期
关键词
historic modifications; H3K4; trimethylation; gene expression; SAGE; mixed-lineage leukemia (MLL);
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
We examined the molecular determinants for sustained high-level expression of "privileged" genes, defined as the 0.03% most highly expressed genes within any specific cell. We identified historic modifications by chromatin immunoprecipitation analyses on Keratin 8, the most highly expressed gene in the human breast cancer cell line, MCF-7, based on serial analysis of gene expression. Quantitative comparisons to the "normal" counterpart cell line, MCF-10A, expressing 350-fold lower levels of Keratin 8 and other breast cancer cell lines expressing higher levels were performed using real-time PCR. Extraordinarily high levels of trimethyl historic H3 lysine 4 (H3K4) were found primarily in the first intron of the Keratin 8 gene stretching from 400 to 2000 bp downstream from the promoter in all breast cancer cells lines but not in MCF-10A cells. The highest levels of historic H3K4 trimethylation in MCF-7 cells ranged from 70% to 80% over input within 1200 bp of this region. Knockdown of mixed-lineage leukemia (MLL), the specific methyltransferase for historic H3K4, with MLL-specific siRNA decreased histone H3K4 trimethylation on the Keratin 8 gene and decreased Keratin 8 mRNA levels. Historic H3K4 trimethylation mediates approximately 86% of the elevated, sustained expression of the Keratin 8 gene in MCF-7 cells.
引用
收藏
页码:271 / 282
页数:12
相关论文
共 28 条
  • [1] Genomic maps and comparative analysis of histone modifications in human and mouse
    Bernstein, BE
    Kamal, M
    Lindblad-Toh, K
    Bekiranov, S
    Bailey, DK
    Huebert, DJ
    McMahon, S
    Karlsson, EK
    Kulbokas, EJ
    Gingeras, TR
    Schreiber, SL
    Lander, ES
    [J]. CELL, 2005, 120 (02) : 169 - 181
  • [2] Brotherick I, 1998, CYTOMETRY, V32, P301, DOI 10.1002/(SICI)1097-0320(19980801)32:4<301::AID-CYTO7>3.3.CO
  • [3] 2-R
  • [4] Cianga Corina, 2002, Rev Med Chir Soc Med Nat Iasi, V106, P720
  • [5] GODFROID E, 1991, J CELL SCI, V99, P595
  • [6] Gonias SL, 2001, FRONT BIOSCI, V6, P1403
  • [7] Nuclear localization of cytokeratin 8 and the O-linked N-acetylglucosamine-containing epitope H in epithelial cells of infiltrating ductal breast carcinomas:: A combination of immunogold and EDTA regressive staining methods
    Havaki, Sophia
    Voloudakis-Baltatzis, Irene
    Goutas, Nikos
    Arvanitis, Leonidas D.
    Vassilaros, Stamatis D.
    Arvanitis, Dimitrios L.
    Kittas, Christos
    Marinos, Evangelos
    [J]. ULTRASTRUCTURAL PATHOLOGY, 2006, 30 (03) : 177 - 186
  • [8] Heterochromatin protein 1: don't judge the book by its cover!
    Hediger, F
    Gasser, SM
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 2006, 16 (02) : 143 - 150
  • [9] HEMBROUGH TA, 1995, J CELL SCI, V108, P1071
  • [10] Cell-surface cytokeratin 8 is the major plasminogen receptor on breast cancer cells and is required for the accelerated activation of cell-associated plasminogen by tissue-type plasminogen activator
    Hembrough, TA
    Li, L
    Gonias, SL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (41) : 25684 - 25691